Author(s): Kanayo Patrick Osemene, Matthew Olugbenga Ilori, Anthony Elujoba

Email(s): osemenekanayo@yahoo.com

DOI: Not Available

Address: Kanayo Patrick Osemene1*, Matthew Olugbenga Ilori2and Anthony Elujoba3
1Department of Clinical Pharmacy & Pharmacy Administration, Obafemi Awolowo University, Nigeria.
2Technology Planning and Development Unit, Obafemi Awolowo University, Nigeria.
3Department of Pharmacognosy, Obafemi Awolowo University, Nigeria: *Corresponding Author

Published In:   Volume - 6,      Issue - 6,     Year - 2013


ABSTRACT:
The commercialization of herbal medicine R&D outputs in Nigeria has not been widely studied. Hence this study examined the extent, evaluated the constraints and factors influencing herbal medicine commercialization. This is with a view to formulating strategies to enhance their commercialization. Opinion of 100 herbal medicine scientists in 13 universities, 100 herbal medicine scientists in 3 research institutes, 125 scientists in 50 herbal medicine manufacturing pharmaceutical firms in Nigeria were sort in order to determine the extent of herbal medicines commercialization, constraints in commercializing them as well as factors influencing their commercialization. This was done through the instrumentality of questionnaire backed with oral personal interview. Data were analyzed using descriptive and inferential statistics. Results from the study revealed that total herbal medicine commercialized was 1010. Herbal medicine scientists rated major constraints in commercializing herbal medicine on a 5-point Likert Scale as inadequate funding of R&D (4.73), inconsistent government policies on funds allocation for research (4.68), lack of interest for local R&D results by the industry (3.91), poor industry academic linkage (3.82) and lack of adequate infrastructural facilities such as electricity, building (3.70). Lack of adequate support for SME’s (3.62) and apathy of financial institutions such as banks to invest in R&D activities (3.60) There were significant correlations between herbal medicine commercialization and market (Y1), technology push (Y2), availability of markets (Y3), availability of inputs (Y4) and strategy adopted by the organization (Y9). Regression analysis revealed that market pull Beta 1 (2.077), presence of customers Beta 3 (3.618) ,availability of inputs Beta 4 (4.061), commitment of developers Beta 8 (3.678) and Beta 9 (4.491),strategy adopted by the organizations contributed significantly to the commercialization process at probability levels of 5% and 10% respectively. Strategies for improving commercialization of herbal medicines were increased capacity building (68.75%), adequate R&D funding (75%), improved R&D infrastructure (70%), improved linkage between the academia and the industry (65%) among others. The study concluded that the commercialization of herbal medicines in Nigeria is low, in spite of the large number of herbal medicines already developed by various research bodies. Therefore, the suggested that the economic and institutional constraints hampering herbal medicine commercialization process must be tackled by the government. This could be done by creating a salubrious environment that would guarantee industrial peace and maintain consistent economic and industrial policy.


Cite this article:
Kanayo Patrick Osemene, Matthew Olugbenga Ilori, Anthony Elujoba. Assessing the Commercialization of Herbal Medicines Research and Development outputs in Nigeria. Research J. Pharm. and Tech 6(6): June 2013; Page 622-631.


Recomonded Articles:

Author(s): Niharika, Navneet Verma

DOI: 10.5958/0974-360X.2016.00182.7         Access: Open Access Read More

Author(s): Ravindranath S. Misal, Vishawas R. Potphode, Vijay R. Mahajan

DOI: 10.5958/0974-360X.2017.00218.9         Access: Open Access Read More

Author(s): U.S Mahadeva Rao, Khamsah Suryati Mohd, Abdurrazaq Muhammad, Bashir Ado Ahmad, Mohaslinda Mohamad, Rosmawati Mat Ali

DOI: Not Available         Access: Open Access Read More

Author(s): Sandeep D. S, Prashant Nayak, Jobin Jose, Rishal Relita M, Sumana D. R.

DOI: 10.5958/0974-360X.2017.00317.1         Access: Open Access Read More

Author(s): Archana Kushwaha, Jayanti Jaiswal, Priya Singh, Neha Rathore, Jai Prakash Dhruw, Ishu Sahu, Chhaya Singh, Krinsha Kumar Sahu, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00270.0         Access: Open Access Read More

Author(s): Homendra Kumar Sahu, Kamdev Sen, Raju Patel, Hulash Sahu, Deepika Sahu, Gulshan Sahu, Chandrashekhar Jain, Narayan Prasad Chandra, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00173.1         Access: Open Access Read More

Author(s): Vikram Kumar Sahu, Amit Mishra, Nitin Sharma, Pratap Kumar Sahu, Shubhini A. Saraf

DOI: 10.5958/0974-360X.2017.00048.8         Access: Open Access Read More

Author(s): Narendra Chotai, Vishnu Patel, Harsha Patel, Uren Patel, Rajendra Kotadiya

DOI:         Access: Open Access Read More

Author(s): Rao Rekha, Goswami Anju, Shekhar Shishant, Mahant Sheefali, Nanda Sanju

DOI: Not Available         Access: Open Access Read More

Author(s): Hitesh Jain, Rushi Panchal, Dilrose Pabla, Jaimini Patel, Mansi Khirwadkar

DOI: Not Available         Access: Open Access Read More

Author(s): Surya Prakash BN Gupta, Neeraj Upmanyu, Gopal Garg

DOI: Not Available         Access: Open Access Read More

Author(s): Oruganti Sai Koushik, V. Himaja, P. Srinivasa Babu, Ramadoss Karthikeyan

DOI: 10.5958/0974-360X.2015.00298.X         Access: Open Access Read More

Author(s): H.B. Pagar, U.P. Shinde, Y.S. Agrawal, S.D. Barhate, T.S. Luhade, R.O. Sonawane

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 


Recent Articles




Tags